Alpa Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
ALPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alpa Laboratories has filed a regulatory disclosure confirming that no new encumbrances (such as pledges or liens) have been created on the company's shares by the promoters or promoter group during the financial year ended March 31, 2025. The disclosure, signed by promoter M.S. Chawla and the Company Secretary, was submitted to both NSE and BSE as part of annual compliance requirements under SEBI's takeover regulations. This means the shares held by promoters remain unencumbered beyond what was already previously disclosed to the stock exchanges.
This is a routine annual compliance filing with no material impact on shareholders. The absence of new encumbrances is a neutral to mildly reassuring signal, indicating promoters have not pledged additional shares as collateral, but it carries no direct bearing on stock price or business operations.